NEO-GAP: A phase II single-arm prospective feasibility study of neoadjuvant gemc
- This topic has 0 replies, 1 voice, and was last updated 2 years, 1 month ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
NEO-GAP: A phase II single-arm prospective feasibility study of neoadjuvant gemcitabine/cisplatin/nab-paclitaxel for resectable high-risk intrahepatic cholangiocarcinoma.
https://meetings.asco.org/abstracts-presentations/211092
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.